CVS Health Corp. on March 16 began offering GlaxoSmithKline PLC's new Shingrix shingles vaccine at all CVS Pharmacy locations in the U.S.
The move follows the licensing of the vaccine by the U.S. Food and Drug Administration in 2017 and its recommendation by the Centers for Disease Control and Prevention.
The Rhode Island-based drug retailer said healthy adults aged 50 and up are recommended to get two doses of the vaccine, two to six months apart, with 99% of people in the age category at risk of getting shingles in their lifetime.
